Add Yahoo as a preferred source to see more of our stories on Google. NEW YORK (AP) -- Osiris Therapeutics said Friday that Medicare reimbursement rates for outpatient use of its wound care product ...
COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company, focused on developing and marketing products to treat conditions in ...
LONDON, March 31, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a peer-reviewed study in the Advances in Wound Care ...
We developed a method, named GraFix, that considerably improves sample quality for structure determination by single-particle electron cryomicroscopy (cryo-EM). GraFix uses a glycerol gradient ...
COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound ...
Results were presented from Protocol 302, a multi-center, randomized, controlled study that was conducted to compare the safety and effectiveness of Grafix to standard of care in patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results